The high supplementation level of FCRW resulted in the lowest relative expression levels of il-1β and il-6, while the same treatment yielded the highest relative expression levels of il-10 and tgf-β compared with the HF group. The gene discussed is TGFB1; the disease is hydrops fetalis.